Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin (Q44070700)

29 November 2017

Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin (English)

1 reference

29 November 2017

1 reference

Ihara Y

1

1 reference

29 November 2017

Suzuki YJ

2

1 reference

29 November 2017

Kitta K

3

1 reference

29 November 2017

Jones LR

4

1 reference

29 November 2017

Ikeda T

5

1 reference

29 November 2017

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

32

1 reference

29 November 2017

1

1 reference

29 November 2017

21-29

1 reference

Left ventricular hypertrophy and mortality--results from the Framingham Study

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Sarcoplasmic reticulum calsequestrins: structural and functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Modulation of focal and global Ca2+ release in calsequestrin-overexpressing mouse cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Regulation of GATA-4 and AP-1 in transgenic mice overexpressing cardiac calsequestrin

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Remodelling of Cardiac Extracellular Matrix duringβ-adrenergic Stimulation: Upregulation of SPARC in the Myocardium of Adult Rats,

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Elevation of Expression of Smads 2, 3, and 4, Decorin and TGF-βin the Chronic Phase of Myocardial Infarct Scar Healing

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Microfibril-associated glycoprotein-2 (MAGP-2) is specifically associated with fibrillin-containing microfibrils but exhibits more restricted patterns of tissue localization and developmental expression than its structural relative MAGP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Amino-acid sequence of a Ca2+ + Mg2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Unchanged Protein Levels of SERCA II and Phospholamban but Reduced Ca 2+ Uptake and Ca 2+ -ATPase Activity of Cardiac Sarcoplasmic Reticulum From Dilated Cardiomyopathy Patients Compared With Patients With Nonfailing Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Structure-function of the ADP/ATP carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4160%2802%2900096-9

7 January 2021

10.1016/S0143-4160(02)00096-9

Identifiers

DOI

1 reference

29 November 2017

1 reference